REPATHA Inj Lös 140 mg/ml Pen (Evolocumab PFS) 140mg/ml

REPATHA Inj Lös 140 mg/ml Pen contains evolocumab, a prescription medicine used to lower cholesterol levels. This pre-filled pen delivers a 140mg/ml dose for subcutaneous injection. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance.

Strength

140mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

AMGEN SWITZERLAND AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Evolocumab is prescribed to reduce low-density lipoprotein (LDL) cholesterol in adults with high cholesterol or certain genetic conditions. It is also used alongside diet and other cholesterol-lowering therapies for patients who cannot control cholesterol with standard treatments. Evolocumab works by helping the liver remove more LDL cholesterol from the blood.

Side Effects

After injection, evolocumab helps the body process cholesterol more effectively, which may lead to improved lipid profiles over time. Users often notice gradual changes in their cholesterol levels when used consistently as directed. Some may experience mild injection-site reactions like redness or itching.

Precautions & Warnings

Keep the pen refrigerated between 2–8°C and protect it from light. Do not freeze or shake vigorously. Allow the pen to reach room temperature for 30 minutes before use if stored cold. Discard used pens properly and avoid reuse. Always check the solution for particles or discoloration before injecting.

Avoid Interactions

Evolocumab is a monoclonal antibody and does not interact with most medications metabolized by the liver. However, it may be used alongside statins or other lipid-lowering drugs unless otherwise directed. No known severe interactions with common over-the-counter products like vitamins or herbal supplements have been reported.

Frequently Asked Questions

It is a subcutaneous injection, typically given once every two weeks or monthly, as prescribed by a healthcare provider.

Consult your doctor before use, as individual conditions may affect suitability and dosing.

Contact your healthcare provider for guidance; do not take a double dose to make up for a missed one.

The safety of evolocumab in pregnancy has not been established; discuss risks and benefits with your physician.

Store refrigerated between 2–8°C and avoid freezing. Do not use if frozen or expired.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.